Blueprint Medicines Corp
BPMCDelisted Jul 18, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597264
Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Blueprint Medicines Corp as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 289
- +13 vs. Q2 2021
- Shares held
- 59.6M
- +1.91M (+3.3%) vs. Q2 2021
- Total value
- $6.13B
- +$1.05B (+20.7%) vs. Q2 2021
- New holders
- 42
- 99 more added
- Sold out
- 29
- 94 more reduced
5 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BPMC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $129 |
| Q1 2026 | 6 | $38.6K |
| Q4 2025 | 8 | $2.57M |
| Q3 2025 | 12 | $2.58M |
| Q2 2025 | 356 | $8.65B |
| Q1 2025 | 353 | $6.12B |
| Q4 2024 | 346 | $5.86B |
| Q3 2024 | 319 | $6.04B |
| Q2 2024 | 305 | $7.15B |
| Q1 2024 | 282 | $6.25B |
| Q4 2023 | 260 | $5.91B |
| Q3 2023 | 220 | $3.25B |
| Q2 2023 | 222 | $4.03B |
| Q1 2023 | 215 | $2.84B |
| Q4 2022 | 223 | $2.74B |
| Q3 2022 | 240 | $4.15B |
| Q2 2022 | 237 | $3.19B |
| Q1 2022 | 248 | $3.82B |
| Q4 2021 | 280 | $6.32B |
| Q3 2021 | 289 | $6.13B |
| Q2 2021 | 281 | $5.14B |
| Q1 2021 | 264 | $5.69B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Blueprint Medicines Corp; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Magnetar Financial LLC | 0 | $0 | 0.00% | −6,454−100.0% | Sold out |
| Quantitative Systematic Strategies LLC | 0 | $0 | 0.00% | −5,990−100.0% | Sold out |
| SG3 Management, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −3,915−100.0% | Sold out |
| Spouting Rock Asset Management, LLC | 0 | $0 | 0.00% | −3,833−100.0% | Sold out |
| NN Investment Partners Holdings N.V. | 0 | $0 | 0.00% | −3,300−100.0% | Sold out |
| Illinois Municipal Retirement Fund | 0 | $0 | 0.00% | −2,990−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −2,966−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −2,864−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −2,529−100.0% | Sold out |
| Pearl River Capital, LLC | 0 | $0 | 0.00% | −2,476−100.0% | Sold out |
| Brown Brothers Harriman & Co | 0 | $0 | 0.00% | −1,566−100.0% | Sold out |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −1,455−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −783−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −715−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Beck Bode, LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Pictet Asset Management Ltd | – | – | – | – | Not filed |
| QS Investors, LLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |
| First Horizon Corp | – | – | – | – | Not filed |
| Smith Asset Management Group LP | – | – | – | – | Not filed |